7th Obesity & NASH Drug Development Summit

7th Obesity & NASH Drug Development Summit

 November 27 to November 29, 2023 

The Westin Boston Seaport District, 425 Summer Street, Boston, Massachusetts, 02210, United States

Welcome to the 7th Obesity & NASH Drug Development Summit, scheduled from Mon, 27 Nov 2023, at 09:25 to Wed, 29 Nov 2023, at 16:00. Eli Lilly's 'triple G' drug, retatrutide, revolutionizes obesity treatment with a groundbreaking 24% weight loss, igniting investment in the metabolic field. Simultaneously, Madrigal's THR β-selective agonist heralds the potential first approved NASH treatment, marking a pivotal era in metabolic drug development. This summit convenes industry experts to assess biomarkers for regulatory approval, delve into GLP-1 RAs with FGF21, GIP, Amylin, and glucagon receptors, and explore combination therapies for efficacy and safety. Join 160+ experts from leading pharmaceuticals to pave the way for innovative weight-loss drugs and the first NASH approval. 

[Read on obesity-and-nash-summit.com](https://obesity-and-nash-summit.com/)

Continue reading at

Related Offerings

Interested in this event?

Next Event

  • November

    3rd International Conference on Otorhinolaryngology

     November 27 to November 28, 2023 

    Dubai, UAE

    3rd International Conference on Otorhinolaryngology

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.

© 2024 Netspective Media LLC. All Rights Reserved.

Built on Feb 29, 2024 at 10:43am